Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-21

FDA Approved: DAURISMO — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved DAURISMO (glasdegib) from Pfizer as an original NDA for the treatment of adults with acute myeloid leukemia who are not candidates for intensive ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daurismo (glasdegib)

Snippet

ORIG AP for DAURISMO (GLASDEGIB)